Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer.

Dholakia, Jhalak; Llamocca, Elyse; Quick, Allison; Salani, Ritu; Felix, Ashley S

Dholakia, Jhalak; Llamocca, Elyse; Quick, Allison; Salani, Ritu; Felix, Ashley S.

Afiliação

Dholakia J; Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH, United States of America.
Llamocca E; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, United States of America.
Quick A; Department of Radiation Oncology, The Ohio State University, Columbus, OH, United States of America.
Salani R; Division of Gynecologic Oncology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.
Felix AS; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, United States of America. Electronic address: Felix.20@osu.edu.

Gynecol Oncol ; 157(3): 716-722, 2020 06.

Article em En | MEDLINE | ID: mdl-32217002

Assuntos

Neoplasias do Endométrio/mortalidade; Adolescente; Adulto; Idoso; Neoplasias do Endométrio/terapia; Feminino; Humanos; Pessoa de Meia-Idade; Análise de Sobrevida; Adulto Jovem

Palavras-chave

Chemotherapy; Disparities; Hospital-based cancer registry; Race; Radiation treatment; Uterus neoplasm

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio Tipo de estudo: Guideline / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google